AAV Technology - Catalent Cell & Gene Therapy

Catalent's AAV Technology and Cell & Gene Therapy division is a global biologics CDMO partner offering end-to-end services for cell and gene therapies. The organization provides comprehensive support spanning cell line and viral vector development, drug substance manufacturing, fill/finish operations, and commercial supply. Services are backed by advanced technologies, global manufacturing capacity, and decades of proven expertise in biologics development and commercialization. The team emphasizes collaboration, flexibility, and quality assurance throughout program lifecycle, from early development through clinical and commercial stages.